While our epitope screen and analyses mapping clonotypes to publicly available references were able to identify tumor antigen specificity in a subset of KIR+CD8+ T cells, the epitope specificity of the remaining of KIR+CD8+ T cells is unknown. The gene discussed is KIR3DL1; the disease is neoplasm.